ID   DUSTY_HUMAN             Reviewed;         929 AA.
AC   Q6XUX3; B7ZL64; O75060; Q17R94; Q5RKT0; Q6IN87; Q6P997; Q86Y03;
AC   Q9P1S5;
DT   02-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   12-APR-2017, entry version 124.
DE   RecName: Full=Dual serine/threonine and tyrosine protein kinase;
DE            EC=2.7.12.1;
DE   AltName: Full=Dusty protein kinase;
DE            Short=Dusty PK;
DE   AltName: Full=RIP-homologous kinase;
DE   AltName: Full=Receptor-interacting serine/threonine-protein kinase 5;
DE   AltName: Full=Sugen kinase 496;
DE            Short=SgK496;
GN   Name=DSTYK; Synonyms=KIAA0472, RIP5, RIPK5, SGK496; ORFNames=HDCMD38P;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=17123648; DOI=10.1016/j.bbaexp.2006.10.004;
RA   Peng J., Dong W., Chen Y., Mo R., Cheng J.-F., Hui C.-C., Mohandas N.,
RA   Huang C.-H.;
RT   "Dusty protein kinases: primary structure, gene evolution, tissue
RT   specific expression and unique features of the catalytic domain.";
RL   Biochim. Biophys. Acta 1759:562-572(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Dendritic cell;
RA   Zhao Z., Huang X., Li N., Zhu X., Cao X.;
RT   "A novel gene from human dendritic cell.";
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Brain, Eye, Muscle, Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 565-929 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9455484; DOI=10.1093/dnares/4.5.345;
RA   Seki N., Ohira M., Nagase T., Ishikawa K., Miyajima N., Nakajima D.,
RA   Nomura N., Ohara O.;
RT   "Characterization of cDNA clones in size-fractionated cDNA libraries
RT   from human brain.";
RL   DNA Res. 4:345-349(1997).
RN   [6]
RP   FUNCTION, TISSUE SPECIFICITY, AND MUTAGENESIS OF LYS-681.
RX   PubMed=15178406; DOI=10.1016/j.bbrc.2004.04.194;
RA   Zha J., Zhou Q., Xu L.G., Chen D., Li L., Zhai Z., Shu H.B.;
RT   "RIP5 is a RIP-homologous inducer of cell death.";
RL   Biochem. Biophys. Res. Commun. 319:298-303(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [9]
RP   INVOLVEMENT IN CAKUT1, VARIANTS CAKUT1 GLN-29; GLY-200 AND LEU-843,
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=23862974; DOI=10.1056/NEJMoa1214479;
RA   Sanna-Cherchi S., Sampogna R.V., Papeta N., Burgess K.E., Nees S.N.,
RA   Perry B.J., Choi M., Bodria M., Liu Y., Weng P.L., Lozanovski V.J.,
RA   Verbitsky M., Lugani F., Sterken R., Paragas N., Caridi G., Carrea A.,
RA   Dagnino M., Materna-Kiryluk A., Santamaria G., Murtas C.,
RA   Ristoska-Bojkovska N., Izzi C., Kacak N., Bianco B., Giberti S.,
RA   Gigante M., Piaggio G., Gesualdo L., Kosuljandic Vukic D.,
RA   Vukojevic K., Saraga-Babic M., Saraga M., Gucev Z., Allegri L.,
RA   Latos-Bielenska A., Casu D., State M., Scolari F., Ravazzolo R.,
RA   Kiryluk K., Al-Awqati Q., D'Agati V.D., Drummond I.A., Tasic V.,
RA   Lifton R.P., Ghiggeri G.M., Gharavi A.G.;
RT   "Mutations in DSTYK and dominant urinary tract malformations.";
RL   N. Engl. J. Med. 369:621-629(2013).
CC   -!- FUNCTION: Acts as a positive regulator of ERK phosphorylation
CC       downstream of fibroblast growth factor-receptor activation. May
CC       induce both caspase-dependent apoptosis and caspase-independent
CC       cell death. {ECO:0000269|PubMed:15178406,
CC       ECO:0000269|PubMed:23862974}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17123648,
CC       ECO:0000269|PubMed:23862974}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q6XUX1}. Apical cell membrane
CC       {ECO:0000269|PubMed:23862974}. Basolateral cell membrane
CC       {ECO:0000269|PubMed:23862974}. Cell junction
CC       {ECO:0000250|UniProtKB:Q6XUX1}. Note=Detected at apical cell-cell
CC       junctions. Colocalized with FGF receptors to the cell membrane (By
CC       similarity). Detected in basolateral and apical membranes of all
CC       tubular epithelia. {ECO:0000250|UniProtKB:Q6XUX1,
CC       ECO:0000269|PubMed:23862974}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q6XUX3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6XUX3-2; Sequence=VSP_018034;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q6XUX3-3; Sequence=VSP_018031;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q6XUX3-4; Sequence=VSP_018030, VSP_018032, VSP_018033;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in skeletal muscle and
CC       testis. Expressed in basolateral and apical membranes of all
CC       tubular epithelia. Expressed in thin ascending limb of the loop of
CC       Henle and the distal convoluted tubule. Expressed in all layers of
CC       transitional ureteric epithelium and in the ureteric smooth-muscle
CC       cells. Weakly expressed in heart, brain, placenta, kidney,
CC       pancreas, spleen, thymus, prostate, uterus, small intestine, white
CC       blood cells, stomach, spinal cord and adrenal gland. Is widely
CC       distributed in the CNS. Also detected in several tumor cell lines.
CC       {ECO:0000269|PubMed:15178406, ECO:0000269|PubMed:17123648,
CC       ECO:0000269|PubMed:23862974}.
CC   -!- DISEASE: Congenital anomalies of the kidney and urinary tract 1
CC       (CAKUT1) [MIM:610805]: A disorder encompassing a broad spectrum of
CC       renal and urinary tract malformations that include renal agenesis,
CC       kidney hypodysplasia, multicystic kidney dysplasia, duplex
CC       collecting system, posterior urethral valves and ureter
CC       abnormalities. Congenital anomalies of kidney and urinary tract
CC       are the commonest cause of chronic kidney disease in children.
CC       {ECO:0000269|PubMed:23862974}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY208850; AAP42418.1; -; mRNA.
DR   EMBL; AY429674; AAS55390.1; -; mRNA.
DR   EMBL; AF068286; AAF65505.1; -; mRNA.
DR   EMBL; AC093422; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC048204; AAH48204.1; -; mRNA.
DR   EMBL; BC053627; AAH53627.1; -; mRNA.
DR   EMBL; BC060870; AAH60870.2; -; mRNA.
DR   EMBL; BC072406; AAH72406.1; -; mRNA.
DR   EMBL; BC117411; AAI17412.1; -; mRNA.
DR   EMBL; BC143603; AAI43604.1; -; mRNA.
DR   EMBL; AB007941; BAA32317.1; -; mRNA.
DR   CCDS; CCDS1451.1; -. [Q6XUX3-1]
DR   CCDS; CCDS1452.1; -. [Q6XUX3-2]
DR   RefSeq; NP_056190.1; NM_015375.2. [Q6XUX3-1]
DR   RefSeq; NP_955749.1; NM_199462.2. [Q6XUX3-2]
DR   UniGene; Hs.6874; -.
DR   ProteinModelPortal; Q6XUX3; -.
DR   SMR; Q6XUX3; -.
DR   BioGrid; 117313; 36.
DR   IntAct; Q6XUX3; 1.
DR   STRING; 9606.ENSP00000356130; -.
DR   BindingDB; Q6XUX3; -.
DR   ChEMBL; CHEMBL1908386; -.
DR   GuidetoPHARMACOLOGY; 2008; -.
DR   iPTMnet; Q6XUX3; -.
DR   PhosphoSitePlus; Q6XUX3; -.
DR   BioMuta; DSTYK; -.
DR   DMDM; 296434486; -.
DR   EPD; Q6XUX3; -.
DR   MaxQB; Q6XUX3; -.
DR   PaxDb; Q6XUX3; -.
DR   PeptideAtlas; Q6XUX3; -.
DR   PRIDE; Q6XUX3; -.
DR   DNASU; 25778; -.
DR   Ensembl; ENST00000367161; ENSP00000356129; ENSG00000133059. [Q6XUX3-2]
DR   Ensembl; ENST00000367162; ENSP00000356130; ENSG00000133059. [Q6XUX3-1]
DR   Ensembl; ENST00000615388; ENSP00000478016; ENSG00000133059. [Q6XUX3-4]
DR   GeneID; 25778; -.
DR   KEGG; hsa:25778; -.
DR   UCSC; uc001hbw.4; human. [Q6XUX3-1]
DR   CTD; 25778; -.
DR   DisGeNET; 25778; -.
DR   GeneCards; DSTYK; -.
DR   H-InvDB; HIX0018906; -.
DR   HGNC; HGNC:29043; DSTYK.
DR   HPA; HPA044140; -.
DR   MalaCards; DSTYK; -.
DR   MIM; 610805; phenotype.
DR   MIM; 612666; gene.
DR   neXtProt; NX_Q6XUX3; -.
DR   OpenTargets; ENSG00000133059; -.
DR   Orphanet; 93100; Unilateral renal agenesis.
DR   PharmGKB; PA164718861; -.
DR   eggNOG; KOG0192; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00840000129948; -.
DR   InParanoid; Q6XUX3; -.
DR   KO; K16288; -.
DR   OMA; PVFFFKV; -.
DR   OrthoDB; EOG091G03P4; -.
DR   PhylomeDB; Q6XUX3; -.
DR   TreeFam; TF331821; -.
DR   SignaLink; Q6XUX3; -.
DR   ChiTaRS; DSTYK; human.
DR   GeneWiki; RIPK5; -.
DR   GenomeRNAi; 25778; -.
DR   PRO; PR:Q6XUX3; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000133059; -.
DR   CleanEx; HS_DSTYK; -.
DR   Genevisible; Q6XUX3; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; IDA:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB.
DR   GO; GO:0045743; P:positive regulation of fibroblast growth factor receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0033674; P:positive regulation of kinase activity; IMP:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell junction; Cell membrane;
KW   Coiled coil; Complete proteome; Cytoplasm; Disease mutation; Kinase;
KW   Membrane; Nucleotide-binding; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Tyrosine-protein kinase.
FT   CHAIN         1    929       Dual serine/threonine and tyrosine
FT                                protein kinase.
FT                                /FTId=PRO_0000233118.
FT   DOMAIN      652    906       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     658    666       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COILED      189    215       {ECO:0000255}.
FT   COILED      395    431       {ECO:0000255}.
FT   COMPBIAS     15     22       Poly-Gly.
FT   COMPBIAS     69     72       Poly-Gly.
FT   ACT_SITE    777    777       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     681    681       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   VAR_SEQ       1    539       Missing (in isoform 4).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_018030.
FT   VAR_SEQ     451    792       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_018031.
FT   VAR_SEQ     703    718       SLPKHERLVDLHGSVI -> WVLASFISMRKIQRRI (in
FT                                isoform 4). {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_018032.
FT   VAR_SEQ     719    929       Missing (in isoform 4).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_018033.
FT   VAR_SEQ     824    868       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_018034.
FT   VARIANT      29     29       R -> Q (in CAKUT1; unknown pathological
FT                                significance; dbSNP:rs200780796).
FT                                {ECO:0000269|PubMed:23862974}.
FT                                /FTId=VAR_071324.
FT   VARIANT     200    200       D -> G (in CAKUT1).
FT                                {ECO:0000269|PubMed:23862974}.
FT                                /FTId=VAR_071325.
FT   VARIANT     432    432       L -> V (in dbSNP:rs35845538).
FT                                /FTId=VAR_057101.
FT   VARIANT     843    843       S -> L (in CAKUT1; dbSNP:rs778586547).
FT                                {ECO:0000269|PubMed:23862974}.
FT                                /FTId=VAR_071326.
FT   MUTAGEN     681    681       K->Q: No change.
FT                                {ECO:0000269|PubMed:15178406}.
FT   CONFLICT    247    247       V -> A (in Ref. 4; AAH72406).
FT                                {ECO:0000305}.
FT   CONFLICT    449    449       G -> R (in Ref. 4; AAH60870).
FT                                {ECO:0000305}.
FT   CONFLICT    641    641       C -> R (in Ref. 1; AAP42418/AAS55390, 2;
FT                                AAF65505, 4; AAH53627/AAH72406/AAI17412/
FT                                AAI43604 and 5; BAA32317). {ECO:0000305}.
SQ   SEQUENCE   929 AA;  105206 MW;  8DDAAC289DE21EE7 CRC64;
     MEGDGVPWGS EPVSGPGPGG GGMIRELCRG FGRYRRYLGR LRQNLRETQK FFRDIKCSHN
     HTCLSSLTGG GGAERGPAGD VAETGLQAGQ LSCISFPPKE EKYLQQIVDC LPCILILGQD
     CNVKCQLLNL LLGVQVLPTT KLGSEESCKL RRLRFTYGTQ TRVSLALPGQ YELVHTLVAH
     QGNWETIPEE DLEVQENNED AAHVLAELEV TMHHALLQEV DVVVAPCQGL RPTVDVLGDL
     VNDFLPVITY ALHKDELSER DEQELQEIRK YFSFPVFFFK VPKLGSEIID SSTRRMESER
     SPLYRQLIDL GYLSSSHWNC GAPGQDTKAQ SMLVEQSEKL RHLSTFSHQV LQTRLVDAAK
     ALNLVHCHCL DIFINQAFDM QRDLQITPKR LEYTRKKENE LYESLMNIAN RKQEEMKDMI
     VETLNTMKEE LLDDATNMEF KDVIVPENGE PVGTREIKCC IRQIQELIIS RLNQAVANKL
     ISSVDYLRES FVGTLERCLQ SLEKSQDVSV HITSNYLKQI LNAAYHVEVT FHSGSSVTRM
     LWEQIKQIIQ RITWVSPPAI TLEWKRKVAQ EAIESLSASK LAKSICSQFR TRLNSSHEAF
     AASLRQLEAG HSGRLEKTED LWLRVRKDHA PRLARLSLES CSLQDVLLHR KPKLGQELGR
     GQYGVVYLCD NWGGHFPCAL KSVVPPDEKH WNDLALEFHY MRSLPKHERL VDLHGSVIDY
     NYGGGSSIAV LLIMERLHRD LYTGLKAGLT LETRLQIALD VVEGIRFLHS QGLVHRDIKL
     KNVLLDKQNR AKITDLGFCK PEAMMSGSIV GTPIHMAPEL FTGKYDNSVD VYAFGILFWY
     ICSGSVKLPE AFERCASKDH LWNNVRRGAR PERLPVFDEE CWQLMEACWD GDPLKRPLLG
     IVQPMLQGIM NRLCKSNSEQ PNRGLDDST
//
